Efficacy and Safety of Sorafenib Versus Supportive Care in Egyptian Advanced Hepatocellular Carcinoma Patients

Efficacy and Safety of Sorafenib Versus Supportive Care in Egyptian Advanced Hepatocellular Carcinoma Patients

Objectives: Sorafenib is the standard first-line treatment for HCC. No sufficient data exists regarding its efficacy in the Egyptian population being a costly medication that is not endorsed by insurance and hence is not used in most institutions. This study aimed to evaluate the overall survival [O...

Full description

Bibliographic Details
Main Authors: Noha Salah El Baghdady, Lamia Elwakeel, Mahmoud Ellithy, Nawal Hussein, Sara Shahin, Abdel Rahman El Naggar
Format: Article
Language:English
Published: Ain Shams University 2020-12-01
Series:Archives of Pharmaceutical Sciences Ain Shams University
Subjects:
hepatocellular carcinoma
sorafenib
best supportive care
efficacy
safety
quality of life
Online Access:https://aps.journals.ekb.eg/article_135136.html

Internet

https://aps.journals.ekb.eg/article_135136.html

Similar Items